ALIVUS:NSE
Alivus Life Sciences Ltd
1 323,40 ₹
arrow_downward
-1,03%(-13,80) 1D
9 қаз., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALIVUS...
Open
1 332,00 ₹
High
1 350,50 ₹
Low
1 298,00 ₹
Mkt. cap
162,48 млрд
Avg. vol.
177,16 м.
Volume
131,73 м.
Dividend
0,38%
Quarterly dividend
1,25 ₹
Ex-dividend date
2026 ж. 01 қыр.
P/E ratio
26,99
52-wk high
1 493,80 ₹
52-wk low
819,00 ₹
EPS
49,03 ₹
No. of employees
2 мың
Open
1 332,00 ₹
High
1 350,50 ₹
Low
1 298,00 ₹
Mkt. cap
162,48 млрд
Avg. vol.
177,16 м.
Volume
131,73 м.
Dividend
0,38%
Quarterly dividend
1,25 ₹
Ex-dividend date
2026 ж. 01 қыр.
P/E ratio
26,99
52-wk high
1 493,80 ₹
52-wk low
819,00 ₹
EPS
49,03 ₹
No. of employees
2 мың
News stories
From web sources and news partners
TradingView
·
56 минут бұрын
Retension Pharmaceuticals, Clinical-Stage Developer of Hypertension Therapies, Files for Nasdaq Capital Market IPO
Yahoo Finance
·
1 сағат бұрын
Ruanyun Edai Technology Inc. Receives Nasdaq Minimum Bid Price Deficiency Notice
Quiver Quantitative
·
1 сағат бұрын
Axe Compute Inc. to Ring Nasdaq Opening Bell Amid AI Infrastructure Growth and $3.45 Billion in Signed Contracts
Seeking Alpha
·
46 минут бұрын
Depreciation Subtleties: S&P Earnings Are Vastly Overstated (NYSEARCA:SPY)
About Alivus Life Sciences Ltd
CEOYasir Rawjee
Employees2,27 мың
Founded2001
Headquarters-
SectorPharmaceutical industry
Websitealivus.com